Editorial Comment from Dr Kobayashi to Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.

Authors	Takashi Kobayashi
Journal	International journal of urology : official journal of the Japanese Urological Association (Int J Urol) Vol. 29 Issue 7 Pg. 739 (07 2022) ISSN: 1442-2042 [Electronic] Australia
PMID	35478200 (Publication Type: Editorial, Comment)
Chemical References	COVID-19 Vaccines BNT162 Vaccine
Topics	BNT162 Vaccine COVID-19 (prevention & control) COVID-19 Vaccines (therapeutic use) Carcinoma, Renal Cell (drug therapy) Humans Kidney Neoplasms (drug therapy) SARS-CoV-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!